Evidence map›Paper›PMID 28741705›Full record

ArticleAllergy2018

House dust mites as potential carriers for IgE sensitization to bacterial antigens.

S Dzoro, I Mittermann, Y Resch-Marat, S Vrtala, M Nehr, A M Hirschl, G Wikberg, L Lundeberg, C Johansson, A Scheynius and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Production ofJournal of immunology research · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

S DzoroDepartment of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
I MittermannDepartment of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Y Resch-MaratDepartment of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
S VrtalaDepartment of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
M NehrDivision of Clinical Microbiology, Clinical Institute of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
A M HirschlDivision of Clinical Microbiology, Clinical Institute of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
G WikbergDermatology and Venereology Unit, Karolinska University Hospital, Stockholm, Sweden.
L LundebergDermatology and Venereology Unit, Karolinska University Hospital, Stockholm, Sweden.
C JohanssonDepartment of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
A ScheyniusDepartment of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
R ValentaDepartment of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-5944-3365
Medical University of Vienna · ATKarolinska Institutet · SEKarolinska University Hospital · SE

Funding

Austrian Science Fund FWF F 4602Austrian Science Fund FWF F 4605Austrian Science Fund FWF P 26728Austrian Science Fund FWF P 26728-B20Austrian Science Fund FWF W 1248
6 · The paper itself

Abstract

backgroundIgE reactivity to antigens from Gram-positive and Gram-negative bacteria is common in patients suffering from respiratory and skin manifestations of allergy, but the routes and mechanisms of sensitization are not fully understood. The analysis of the genome, transcriptome and microbiome of house dust mites (HDM) has shown that Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) species are abundant bacteria within the HDM microbiome. Therefore, our aim was to investigate whether HDM are carriers of bacterial antigens leading to IgE sensitization in patients suffering from atopic dermatitis.

methodsPlasma samples from patients with AD (n = 179) were analysed for IgE reactivity to a comprehensive panel of microarrayed HDM allergen molecules and to S. aureus and E. coli by IgE immunoblotting. Antibodies specific for S. aureus and E. coli antigens were tested for reactivity to nitrocellulose-blotted extract from purified HDM bodies, and the IgE-reactive antigens were detected by IgE immunoblot inhibition experiments. IgE antibodies directed to bacterial antigens in HDM were quantified by IgE ImmunoCAP™ inhibition experiments.

resultsIgE reactivity to bacterial antigens was significantly more frequent in patients with AD sensitized to HDM than in AD patients without HDM sensitization. S. aureus and E. coli antigens were detected in immune-blotted HDM extract, and the presence of IgE-reactive antigens in HDM was demonstrated by qualitative and quantitative IgE inhibition experiments.

conclusionHouse dust mites (HDM) may serve as carriers of bacteria responsible for the induction of IgE sensitization to microbial antigens.

Indexed as

ImmunizationAllergensAnimalsAntibodies, BacterialAntigens, BacterialDermatitis, AtopicEpitopesEscherichia coliFemaleHumansHypersensitivityImmunoglobulin EImmunoglobulin GMalePrevalencePyroglyphidaeAllergensAntibodies, BacterialAntigens, BacterialEpitopesImmunoglobulin EImmunoglobulin Gallergens and epitopesatopic dermatitisbasic mechanismshouse dust mites

Identifiers

PMID28741705
PMCPMC5763376
OpenAlexW2739436716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.